TG Therapeutics, Inc.
TGTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001001316
In the last 90 days, TG Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 431 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in TG Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 376
- +49 vs. Q4 2024
- Shares held
- 98.9M
- +3.56M (+3.7%) vs. Q4 2024
- Total value
- $3.90B
- +$1.03B (+35.9%) vs. Q4 2024
- New holders
- 85
- 117 more added
- Sold out
- 36
- 117 more reduced
4 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 431 | $6.10B |
| Q1 2026 | 365 | $3.50B |
| Q4 2025 | 352 | $3.07B |
| Q3 2025 | 354 | $3.58B |
| Q2 2025 | 356 | $3.65B |
| Q1 2025 | 376 | $3.90B |
| Q4 2024 | 331 | $2.92B |
| Q3 2024 | 308 | $2.38B |
| Q2 2024 | 259 | $1.66B |
| Q1 2024 | 241 | $1.38B |
| Q4 2023 | 236 | $1.55B |
| Q3 2023 | 236 | $756.4M |
| Q2 2023 | 244 | $2.19B |
| Q1 2023 | 214 | $1.43B |
| Q4 2022 | 198 | $1.11B |
| Q3 2022 | 183 | $594.6M |
| Q2 2022 | 175 | $452.6M |
| Q1 2022 | 181 | $960.0M |
| Q4 2021 | 194 | $1.90B |
| Q3 2021 | 223 | $3.21B |
| Q2 2021 | 237 | $3.73B |
| Q1 2021 | 240 | $4.77B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding TG Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bayforest Capital Ltd | 0 | $0 | 0.00% | −1,011−100.0% | Sold out |
| PSI Advisors, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −632−100.0% | Sold out |
| LGT Financial Advisors LLC | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −251−100.0% | Sold out |
| GeoWealth Management, LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Center for Financial Planning, Inc. | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| DiNuzzo Private Wealth, Inc. | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Parkworth Wealth Management, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Global Financial Private Client, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Caxton Associates LP | – | – | – | – | Not filed |
| Legacy Investment Solutions, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |